Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lawrence N. Shulman, MD
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
527 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pretoria Academic Hospital
Pretoria, South Africa
- Regional Medical Center
Anniston, Alabama, United States
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- Providence Cancer Center at Providence Hospital
Mobile, Alabama, United States
- Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
- Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants - Castro Valley
Castro Valley, California, United States
- Valley Medical Oncology
Fremont, California, United States
- Washington Township Hospital
Fremont, California, United States
- California Cancer Center - Woodward Park Office
Fresno, California, United States
- Cancer Care Associates
Fresno, California, United States
- Marin Cancer Institute at Marin General Hospital
Greenbrae, California, United States
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Tibotec Therapeutics - Division of Ortho Biotech Products, Lp
Marysville, California, United States
- Memorial Medical Center
Modesto, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Breast Surgeons, Incorporated
Oakland, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Tom K Lee, Incorporated
Oakland, California, United States
- Valley Care Medical Center
Pleasanton, California, United States
- Valley Medical Oncology Consultants - Pleasanton
Pleasanton, California, United States
- Mercy Regional Cancer Center at Mercy Medical Center
Redding, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Naval Medical Center - San Diego
San Diego, California, United States
- California Pacific Medical Center - California Campus
San Francisco, California, United States
- Doctors Medical Center - San Pablo Campus
San Pablo, California, United States
- Sutter Health - Western Division Cancer Research Group
San Rafael, California, United States
- Tahoe Forest Cancer Center
Truckee, California, United States
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Memorial Hospital Cancer Center - Colorado Springs
Colorado Springs, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2002
- Primary completion
- 30 Apr 2012
- Completion
- 30 Jun 2014
- Last update posted
- 18 May 2017
- Registered enrollment
- 3,871
- Registry id
- NCT00041119
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.